$DORM
Dorman Products, Inc.

2018 Q1 Form 10-K Financial Statement

#000156459018003466 Filed on February 27, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q4 2017 Q3
Revenue $227.3M $227.7M $224.6M
YoY Change -0.6% 5.56%
Cost Of Revenue $138.6M $136.8M $136.5M
YoY Change -0.07% 5.28%
Gross Profit $88.60M $90.90M $88.13M
YoY Change -1.41% 5.99%
Gross Profit Margin 38.99% 39.92% 39.23%
Selling, General & Admin $48.60M $47.50M $45.34M
YoY Change 5.32% 9.21%
% of Gross Profit 54.85% 52.26% 51.44%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.400M $6.200M $5.200M
YoY Change 24.0% 10.64%
% of Gross Profit 7.22% 6.82% 5.9%
Operating Expenses $48.70M $47.50M $45.34M
YoY Change 5.32% 9.21%
Operating Profit $39.99M $43.41M $42.79M
YoY Change -7.84% 2.78%
Interest Expense -$100.0K $200.0K
YoY Change 0.0% 227.87%
% of Operating Profit -0.23% 0.47%
Other Income/Expense, Net $152.0K $168.0K
YoY Change
Pretax Income $40.10M $43.30M $42.96M
YoY Change -7.87% 3.33%
Income Tax $9.500M $16.90M $15.95M
% Of Pretax Income 23.69% 39.03% 37.13%
Net Earnings $30.65M $21.97M $27.01M
YoY Change -23.46% 1.17%
Net Earnings / Revenue 13.49% 9.65% 12.02%
Basic Earnings Per Share $0.80
Diluted Earnings Per Share $0.93 $0.65 $0.80
COMMON SHARES
Basic Shares Outstanding 33.57M 33.72M 33.82M
Diluted Shares Outstanding 33.91M

Balance Sheet

Concept 2018 Q1 2017 Q4 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $75.30M $71.70M $129.2M
YoY Change -51.91% 35.86%
Cash & Equivalents $75.34M $71.69M $116.8M
Short-Term Investments
Other Short-Term Assets $8.600M $7.100M $5.000M
YoY Change 129.03% 16.28%
Inventory $205.9M $212.1M $201.8M
Prepaid Expenses
Receivables $250.6M $241.9M $231.1M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $540.4M $532.8M $554.0M
YoY Change -3.4% 8.07%
LONG-TERM ASSETS
Property, Plant & Equipment $92.83M $92.69M $89.90M
YoY Change 4.81% 1.71%
Goodwill $65.91M $66.00M
YoY Change 134.49%
Intangibles $21.75M $22.16M
YoY Change 1249.45%
Long-Term Investments $21.10M
YoY Change
Other Assets $45.41M $44.34M $45.17M
YoY Change 50.18% 52.73%
Total Long-Term Assets $232.7M $233.1M $184.0M
YoY Change 45.51% 18.43%
TOTAL ASSETS
Total Short-Term Assets $540.4M $532.8M $554.0M
Total Long-Term Assets $232.7M $233.1M $184.0M
Total Assets $773.0M $765.9M $738.0M
YoY Change 7.61% 10.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $63.11M $80.22M $72.66M
YoY Change 10.45% 38.45%
Accrued Expenses $26.79M $18.40M $17.58M
YoY Change -4.76% -20.64%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $95.83M $110.8M $100.6M
YoY Change 6.68% 20.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $13.65M $13.73M $9.357M
YoY Change 117.9% 69.02%
Total Long-Term Liabilities $13.65M $13.73M $9.357M
YoY Change 117.9% 69.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $95.83M $110.8M $100.6M
Total Long-Term Liabilities $13.65M $13.73M $9.357M
Total Liabilities $109.5M $124.5M $109.9M
YoY Change 13.04% 23.72%
SHAREHOLDERS EQUITY
Retained Earnings $611.3M $589.7M $583.3M
YoY Change 5.84% 9.01%
Common Stock $45.80M $45.15M $44.83M
YoY Change 1.38% 1.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $657.1M $634.8M $628.1M
YoY Change
Total Liabilities & Shareholders Equity $773.0M $765.9M $738.0M
YoY Change 7.61% 10.48%

Cashflow Statement

Concept 2018 Q1 2017 Q4 2017 Q3
OPERATING ACTIVITIES
Net Income $30.65M $21.97M $27.01M
YoY Change -23.46% 1.17%
Depreciation, Depletion And Amortization $6.400M $6.200M $5.200M
YoY Change 24.0% 10.64%
Cash From Operating Activities $19.75M $34.80M $3.800M
YoY Change -47.27% -80.0%
INVESTING ACTIVITIES
Capital Expenditures $6.276M -$7.100M -$6.300M
YoY Change 36.54% 31.25%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$56.90M $0.00
YoY Change -100.0%
Cash From Investing Activities -$6.276M -$63.80M -$6.400M
YoY Change 1126.92% -41.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -9.771M -16.20M -24.60M
YoY Change 134.78% 3414.29%
NET CHANGE
Cash From Operating Activities 19.75M 34.80M 3.800M
Cash From Investing Activities -6.276M -63.80M -6.400M
Cash From Financing Activities -9.771M -16.20M -24.60M
Net Change In Cash 3.653M -45.20M -27.20M
YoY Change -183.86% -472.6%
FREE CASH FLOW
Cash From Operating Activities $19.75M $34.80M $3.800M
Capital Expenditures $6.276M -$7.100M -$6.300M
Free Cash Flow $13.48M $41.90M $10.10M
YoY Change -41.15% -57.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017 dei Entity Registrant Name
EntityRegistrantName
Dorman Products, Inc.
CY2018Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33568070
CY2017Q3 dei Entity Public Float
EntityPublicFloat
1948324106
CY2017 us-gaap Sales Revenue Net
SalesRevenueNet
903221000
CY2016 us-gaap Sales Revenue Net
SalesRevenueNet
859604000
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
802957000
CY2017 us-gaap Cost Of Goods Sold
CostOfGoodsSold
544572000
CY2016 us-gaap Cost Of Goods Sold
CostOfGoodsSold
521530000
CY2015 us-gaap Cost Of Goods Sold
CostOfGoodsSold
494907000
CY2017 us-gaap Gross Profit
GrossProfit
358649000
CY2016 us-gaap Gross Profit
GrossProfit
338074000
CY2015 us-gaap Gross Profit
GrossProfit
308050000
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
182409000
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
169473000
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
161893000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
176240000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
168601000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
146157000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
348000
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-241000
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-216000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
176588000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
168360000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
69989000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
92329000
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.07
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.60
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.13
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.07
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.60
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33964000
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34516000
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35466000
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34052000
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34598000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71691000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
241880000
CY2017Q4 us-gaap Inventory Net
InventoryNet
212149000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7129000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
532849000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
92692000
CY2017Q4 us-gaap Goodwill
Goodwill
65999000
CY2016Q4 us-gaap Goodwill
Goodwill
28146000
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
22158000
CY2017 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2017 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2017 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2017 dei Entity Central Index Key
EntityCentralIndexKey
0000868780
CY2017 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-30
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1148000
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-24874000
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
20202000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3748000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
790000
CY2017 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4908000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
149121000
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35538000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
230526000
CY2016Q4 us-gaap Inventory Net
InventoryNet
168851000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3116000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
551614000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
88436000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
518036000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
145941000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
62311000
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
53612000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
106599000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
106049000
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.14
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12162000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11899000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18401000
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1642000
CY2017Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
7884000
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
12429000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
44342000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
29525000
CY2017Q4 us-gaap Assets
Assets
765924000
CY2016Q4 us-gaap Assets
Assets
711792000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
80218000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
72629000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19320000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
110781000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
103848000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13732000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6302000
CY2017Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
6604000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
336000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
345000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
44812000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
44187000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
589659000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
557110000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
634807000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
601642000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
765924000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
711792000
CY2017Q4 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
97193000
CY2016Q4 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
99995000
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33571524
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34517633
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33571524
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34517633
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
462061000
CY2015 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
93000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
882000
CY2015 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
37324000
CY2015 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-5000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2380000
CY2016 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
24678000
CY2016 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-145000
CY2017 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
31000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3162000
CY2017 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
76129000
CY2017 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
675000
CY2017 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-1173000
CY2017 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
22224000
CY2016 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
18907000
CY2015 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
16186000
CY2017 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
299000
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1221000
CY2015 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3260000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4676000
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4888000
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5106000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
3162000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
2380000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
882000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5709000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
27824000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
25147000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-821000
CY2016 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4590000
CY2015 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3962000
CY2017 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
3718000
CY2015 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
57151000
CY2015 dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
37324000
CY2015 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2133000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-94437000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-26254000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-23821000
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
31000
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
93000
CY2017 dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
-1173000
CY2016 dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
-145000
CY2015 dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
-5000
CY2017 dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
76129000
CY2016 dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
24678000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-77271000
CY2016 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
8662000
CY2015 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
5389000
CY2017 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-6925000
CY2016 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2462000
CY2015 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3611000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
94241000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
121539000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
92060000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24450000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20059000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21688000
CY2017 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
59987000
CY2017 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
10000000
CY2016 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
6195000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-24823000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-37236000
CY2017 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
37000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-77430000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
70462000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
31003000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78659000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47656000
CY2017 us-gaap Interest Paid
InterestPaid
291000
CY2016 us-gaap Interest Paid
InterestPaid
266000
CY2015 us-gaap Interest Paid
InterestPaid
281000
CY2017 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
74647000
CY2016 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
62348000
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">Use of Estimates in the Preparation of Financial Statements<font style="font-weight:normal;">.</font><font style="font-weight:normal;"> The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></p></div>
CY2017 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">Reclassifications<font style="font-weight:normal;">.</font><font style="font-weight:normal;"> Certain prior year amounts have been reclassified to conform with current-year presentation.</font></p></div>
CY2017 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">Concentrations of Risk<font style="font-weight:normal;">.</font><font style="font-weight:normal;"> Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents and accounts receivable. All cash equivalents are managed within established guidelines which limit the amount which may be invested with one issuer. A significant percentage of our accounts receivable have been, and will continue to be, concentrated among a relatively small number of automotive retailers and warehouse distributors in the United States. Our five largest customers accounted for 85% of net accounts receivable as of December&#160;30, 2017 and 87% of net accounts receivable as of December&#160;31, 2016. We continually monitor the credit terms and credit limits to these and other customers.&nbsp;&nbsp;In fiscal 2017, approximately 71% of our products were purchased from suppliers located in a variety of foreign countries, with the largest portion coming from China.</font></p></div>
CY2017 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3300000
CY2017Q4 dorm Accrued Customer Rebates
AccruedCustomerRebates
6800000
CY2016Q4 dorm Accrued Customer Rebates
AccruedCustomerRebates
7300000
CY2017Q4 us-gaap Equity Method Investments
EquityMethodInvestments
21100000
CY2017Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
500000
CY2016Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
500000
CY2017Q4 dorm Number Of Largest Customer
NumberOfLargestCustomer
5
CY2016Q4 dorm Number Of Largest Customer
NumberOfLargestCustomer
5
CY2017Q4 dorm Number Of Foreign Forward Contracts Outstanding
NumberOfForeignForwardContractsOutstanding
0
CY2016Q4 dorm Number Of Foreign Forward Contracts Outstanding
NumberOfForeignForwardContractsOutstanding
0
CY2017Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
82010000
CY2016Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
72833000
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
126827000
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
93223000
CY2017Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
3312000
CY2016Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
2795000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
212261000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
194165000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
119569000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
105729000
CY2017Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
20200000
CY2016Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
18500000
CY2017 dorm Short Term Investment Original Maturity Period Description
ShortTermInvestmentOriginalMaturityPeriodDescription
three months or less
CY2017 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
582900000
CY2016 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
521900000
CY2015 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
519200000
CY2017Q4 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
380800000
CY2016Q4 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
338300000
CY2017 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
11400000
CY2016 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
8900000
CY2015 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
7200000
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
21500000
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
18700000
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
15900000
CY2015Q4 us-gaap Goodwill
Goodwill
28146000
CY2017 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
37853000
CY2016 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
23016000
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
858000
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
22158000
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2000000
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1642000
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
CY2017Q4 dorm Number Of Outstanding Letters Of Credit
NumberOfOutstandingLettersOfCredit
2
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
4357000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1928000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1862000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1784000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1739000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
11670000
CY2017 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
5400000
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
4200000
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
4500000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1600000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1600000
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1600000
CY2017 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2022-12-31
CY2017 dorm Lease Effective Date
LeaseEffectiveDate
2018-01-01
CY2017Q4 dorm Percentage Of Expense Qualified Property Placed In Service
PercentageOfExpenseQualifiedPropertyPlacedInService
1.00
CY2017Q4 dorm Percentage Of Dividends Received Deduction On Qualifying Dividends Paid By Foreign Subsidiaries
PercentageOfDividendsReceivedDeductionOnQualifyingDividendsPaidByForeignSubsidiaries
1.00
CY2017 dorm Period For First Significant Change In Domestic Tax Law
PeriodForFirstSignificantChangeInDomesticTaxLaw
P30Y
CY2017 dorm Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Asset Income Tax Expense Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetIncomeTaxExpenseBenefit
4400000
CY2017 dorm Tax Cuts And Jobs Act Of2017 Incomplete Accounting Tax On Deferred Foreign Earnings Liquid Assets Percentage
TaxCutsAndJobsActOf2017IncompleteAccountingTaxOnDeferredForeignEarningsLiquidAssetsPercentage
0.155
CY2017 dorm Tax Cuts And Jobs Act Of2017 Incomplete Accounting Tax On Deferred Foreign Earnings Illiquid Assets Percentage
TaxCutsAndJobsActOf2017IncompleteAccountingTaxOnDeferredForeignEarningsIlliquidAssetsPercentage
0.08
CY2017 dorm Tax Cuts And Jobs Act Of2017 Incomplete Accounting Defined Increments Minimum Payment Period
TaxCutsAndJobsActOf2017IncompleteAccountingDefinedIncrementsMinimumPaymentPeriod
P8Y
CY2017 dorm Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Income Tax Expense Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateIncomeTaxExpenseBenefit
0
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
56641000
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
61251000
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
55140000
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
8293000
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
5948000
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3578000
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
379000
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
65313000
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
67199000
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
58718000
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
4582000
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-4563000
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-4874000
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
343000
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-325000
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-232000
CY2017 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-249000
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.034
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.022
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.018
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.003
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.002
CY2015 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.002
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.025
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.010
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.001
CY2017Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
700000
CY2017Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
7335000
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.396
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.370
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.367
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2301000
CY2017Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
2000000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3567000
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1855000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1163000
CY2017 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
181000
CY2017 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
4543000
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
109000
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
177000
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
212000
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
20000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
3005000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
453000
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2033000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
889000
CY2016Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
10337000
CY2017Q4 dorm Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
11732000
CY2016Q4 dorm Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
20216000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
1664000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
2935000
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
261000
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
786000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
20992000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
34274000
CY2017Q4 dorm Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
7936000
CY2016Q4 dorm Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
11988000
CY2017Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
11776000
CY2016Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
9857000
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
19712000
CY2016Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
21845000
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1280000
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
12429000
CY2017Q4 dorm Common Stock Held By Relatives Of Director Percentage
CommonStockHeldByRelativesOfDirectorPercentage
0.20
CY2017Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
50000000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2000000
CY2017 dorm Date Of Plan Approval
DateOfPlanApproval
2009-05-20
CY2017 dorm Maximum Grant Period From Date Of Plan Approval
MaximumGrantPeriodFromDateOfPlanApproval
P10Y
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1399106
CY2017 us-gaap Restricted Stock Expense
RestrictedStockExpense
2800000
CY2016 us-gaap Restricted Stock Expense
RestrictedStockExpense
2300000
CY2015 us-gaap Restricted Stock Expense
RestrictedStockExpense
900000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
72900
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
44104
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
38580
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
35182
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
43242
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
133794
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
29002
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
2671
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
145363
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
70611
CY2016 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
100000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
56953
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
5294
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
153727
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
27.82
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
45.68
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
25.24
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
44.84
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
34.49
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
49.45
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
29.74
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
33.79
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
49.22
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
78.27
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
56.03
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
51.56
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
59.96
CY2017 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
300000
CY2015 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
100000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.27
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.26
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.015
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
75000
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
35000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
40000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
61084
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
101084
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
58024
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
32751
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3810
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
122547
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
22520
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.28
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.76
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.86
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
44.36
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
29.52
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
78.58
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.69
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
56.72
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
57.74
CY2017Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
31.07
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y7M6D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y7M6D
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1402012
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
677188
CY2017Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
122547
CY2017 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y7M6D
CY2017Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
57.74
CY2017Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
22520
CY2017 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
2700000
CY2016 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
2500000
CY2015 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
2700000
CY2017Q4 dorm Number Of Common Stock Held Under Retirement Plan
NumberOfCommonStockHeldUnderRetirementPlan
269628
CY2017 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
19110
CY2016 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
38970
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
40989000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
41633000
us-gaap Operating Income Loss
OperatingIncomeLoss
47048000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
24671000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
25982000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
26695000
us-gaap Net Income Loss
NetIncomeLoss
28701000
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
CY2017 dorm Number Of Largest Customers
NumberOfLargestCustomers
4
CY2017 dorm Entity Wide Revenue Major Customer Aggregate Percentage
EntityWideRevenueMajorCustomerAggregatePercentage
0.61
CY2016 dorm Entity Wide Revenue Major Customer Aggregate Percentage
EntityWideRevenueMajorCustomerAggregatePercentage
0.60
CY2015 dorm Entity Wide Revenue Major Customer Aggregate Percentage
EntityWideRevenueMajorCustomerAggregatePercentage
0.60
CY2017 dorm Export Sales
ExportSales
55800000
CY2016 dorm Export Sales
ExportSales
48600000
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2015 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
33430
CY2017 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1400000
CY2016 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2200000
CY2015 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1600000
CY2017 dorm Stock Repurchased And Retired During Period Average Purchase Price
StockRepurchasedAndRetiredDuringPeriodAveragePurchasePrice
73.34
CY2016 dorm Stock Repurchased And Retired During Period Average Purchase Price
StockRepurchasedAndRetiredDuringPeriodAveragePurchasePrice
56.66
CY2015 dorm Stock Repurchased And Retired During Period Average Purchase Price
StockRepurchasedAndRetiredDuringPeriodAveragePurchasePrice
48.14
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
106000
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
50000
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7500
CY2017 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
88000
CY2016 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
82000
CY2015 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
72000
CY2015 dorm Export Sales
ExportSales
49800000
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
221625000
CY2017Q3 us-gaap Sales Revenue Net
SalesRevenueNet
229262000
CY2017Q3 us-gaap Sales Revenue Net
SalesRevenueNet
224615000
CY2017Q4 us-gaap Sales Revenue Net
SalesRevenueNet
227719000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
45042000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
44999000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
42790000
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
43409000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
29187000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
28437000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
27008000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
21967000
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.85
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.80
CY2017Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
208148000
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
209573000
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
212786000
us-gaap Sales Revenue Net
SalesRevenueNet
229097000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
38931000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83

Files In Submission

Name View Source Status
0001564590-18-003466-index-headers.html Edgar Link pending
0001564590-18-003466-index.html Edgar Link pending
0001564590-18-003466.txt Edgar Link pending
0001564590-18-003466-xbrl.zip Edgar Link pending
dorm-10k_20171230.htm Edgar Link pending
dorm-20171230.xml Edgar Link completed
dorm-20171230.xsd Edgar Link pending
dorm-20171230_cal.xml Edgar Link unprocessable
dorm-20171230_def.xml Edgar Link unprocessable
dorm-20171230_lab.xml Edgar Link unprocessable
dorm-20171230_pre.xml Edgar Link unprocessable
dorm-ex21_6.htm Edgar Link pending
dorm-ex23_7.htm Edgar Link pending
dorm-ex311_8.htm Edgar Link pending
dorm-ex312_9.htm Edgar Link pending
dorm-ex32_10.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2018022718003263723198.jpg Edgar Link pending
g2018022718003276123199.jpg Edgar Link pending
g2018022718003350723200.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending